Literature DB >> 8091326

Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph.

A Tazi1, T Desfemmes-Baleyte, P Soler, D Valeyre, A J Hance, J P Battesti.   

Abstract

BACKGROUND: Several chest radiographic abnormalities have been described in pulmonary sarcoidosis, but a diffuse ground glass pattern is extremely rare.
METHODS: The chest radiographs of more than 1600 patients with sarcoidosis evaluated in our service between 1976 and 1991 were reviewed to determine the prevalence of this pattern on chest radiography at presentation, and to assess the clinical characteristics of these patients.
RESULTS: Ten patients (0.6%) were identified with diffuse ground glass abnormalities on the chest radiography (eight men); all had associated hilar or mediastinal adenopathy. All patients were white and nine were smokers or former smokers. Nine patients were symptomatic and six had inspiratory crackles on physical examination. As a group these patients were remarkable for the frequency and severity of physiological abnormalities and the presence of various findings typically associated with "active" disease. Nine patients were followed for more than three years. All were treated with oral corticosteroids because of significant symptoms or physiological abnormalities, or both. Symptoms and radiological abnormalities disappeared or improved in all patients, but recurred in a high proportion when steroids were tapered or discontinued. By December 1992 only three patients had been withdrawn from treatment.
CONCLUSIONS: A diffuse ground glass pattern on the chest radiograph is unusual in patients with sarcoidosis and may occur more commonly in white subjects and cigarette smokers. Its presence suggests the existence of active disease of recent onset likely to require long term treatment with corticosteroids.

Entities:  

Mesh:

Year:  1994        PMID: 8091326      PMCID: PMC475126          DOI: 10.1136/thx.49.8.793

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  29 in total

1.  Course and prognosis of sarcoidosis around the world.

Authors:  L E Siltzbach; D G James; E Neville; J Turiaf; J P Battesti; O P Sharma; Y Hosoda; R Mikami; M Odaka
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

2.  Radiologic aspects of intrathoracic sarcoidosis.

Authors:  Y M Berkmen
Journal:  Semin Roentgenol       Date:  1985-10       Impact factor: 0.800

3.  The radiology of interstitial lung disease.

Authors:  R G Fraser
Journal:  Clin Chest Med       Date:  1982-09       Impact factor: 2.878

4.  Radiologic findings in farmer's lung. Prognosis and correlation to lung function.

Authors:  S Mönkäre; M Ikonen; T Haahtela
Journal:  Chest       Date:  1985-04       Impact factor: 9.410

5.  Sarcoidosis: epidemiology and prognosis. A 15-year European study.

Authors:  G Hillerdal; E Nöu; K Osterman; B Schmekel
Journal:  Am Rev Respir Dis       Date:  1984-07

Review 6.  Unusual manifestations of thoracic sarcoidosis.

Authors:  S D Rockoff; P K Rohatgi
Journal:  AJR Am J Roentgenol       Date:  1985-03       Impact factor: 3.959

7.  Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking.

Authors:  G R Mason; J M Uszler; R M Effros; E Reid
Journal:  Chest       Date:  1983-01       Impact factor: 9.410

8.  Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy.

Authors:  G M Ainslie; S R Benatar
Journal:  Q J Med       Date:  1985-06

9.  Use of pulmonary function tests in the management of sarcoidosis.

Authors:  R H Winterbauer; J F Hutchinson
Journal:  Chest       Date:  1980-10       Impact factor: 9.410

10.  Crackles (rales) in the interstitial pulmonary diseases.

Authors:  G R Epler; C B Carrington; E A Gaensler
Journal:  Chest       Date:  1978-03       Impact factor: 9.410

View more
  1 in total

Review 1.  Sarcoidosis.

Authors:  D G Peckham; M A Spiteri
Journal:  Postgrad Med J       Date:  1996-04       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.